Condition

Hematuria

ClinicalTrials.gov condition label

Clinical trials5

Recruiting0

Common interventions7

Lead sponsors shown5

Clinical trials

5 shown

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic HyperplasiaNCT05314582 · 2022-03-10

Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the BladderNCT05077852 · 2021-12-12

Intravesical Antifibrinolytic for Patients With Hematuria and Clot RetentionNCT04555343 · 2021-03-01

Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent DeviceNCT03965975 · 2019-06-10

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in CystoscopyNCT03831321 · 2018-12-11

Common interventions

CystoscopyDEVICE1 Diclofenac SodiumDRUG1 Lab Gold StandardDEVICE1 Lubricant GelDRUG1 S-ThereDEVICE1 Tranexamic acidDRUG1 UrethrocystoscopyDIAGNOSTIC_TEST1

Leading sponsors

Ankara Training and Research Hospital1 Bezmialem Vakif University1 Fraser Health1 S-There Technologies SL1 Taha Uçar1

Trial status mix

UNKNOWN3

COMPLETED2

Phase mix

NA1

PHASE11

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.